These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29249906)

  • 1. The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure.
    Nieminen MS; Fonseca C; Brito D; Wikström G
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C15-C21. PubMed ID: 29249906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus.
    Nieminen MS; Altenberger J; Ben-Gal T; Böhmer A; Comin-Colet J; Dickstein K; Edes I; Fedele F; Fonseca C; García-González MJ; Giannakoulas G; Iakobishvili Z; Jääskeläinen P; Karavidas A; Kettner J; Kivikko M; Lund LH; Matskeplishvili ST; Metra M; Morandi F; Oliva F; Parkhomenko A; Parissis J; Pollesello P; Pölzl G; Schwinger RH; Segovia J; Seidel M; Vrtovec B; Wikström G
    Int J Cardiol; 2014 Jun; 174(2):360-7. PubMed ID: 24780540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure.
    Delgado JF; Oliva F; Reinecke A
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C8-C14. PubMed ID: 29249905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
    Silvetti S; Nieminen MS
    Int J Cardiol; 2016 Jan; 202():138-43. PubMed ID: 26386941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
    Pölzl G; Altenberger J; Baholli L; Beltrán P; Borbély A; Comin-Colet J; Delgado JF; Fedele F; Fontana A; Fruhwald F; Giamouzis G; Giannakoulas G; Garcia-González MJ; Gustafsson F; Kaikkonen K; Kivikko M; Kubica J; von Lewinski D; Löfman I; Malfatto G; Manito N; Martínez-Sellés M; Masip J; Merkely B; Morandi F; Mølgaard H; Oliva F; Pantev E; Papp Z; Perna GP; Pfister R; Piazza V; Bover R; Rangel-Sousa D; Recio-Mayoral A; Reinecke A; Rieth A; Sarapohja T; Schmidt G; Seidel M; Störk S; Vrtovec B; Wikström G; Yerly P; Pollesello P
    Int J Cardiol; 2017 Sep; 243():389-395. PubMed ID: 28571618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.
    Nieminen MS; Buerke M; Cohen-Solál A; Costa S; Édes I; Erlikh A; Franco F; Gibson C; Gorjup V; Guarracino F; Gustafsson F; Harjola VP; Husebye T; Karason K; Katsytadze I; Kaul S; Kivikko M; Marenzi G; Masip J; Matskeplishvili S; Mebazaa A; Møller JE; Nessler J; Nessler B; Ntalianis A; Oliva F; Pichler-Cetin E; Põder P; Recio-Mayoral A; Rex S; Rokyta R; Strasser RH; Zima E; Pollesello P
    Int J Cardiol; 2016 Sep; 218():150-157. PubMed ID: 27232927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan.
    Fedele F; Karason K; Matskeplishvili S
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C22-C28. PubMed ID: 29249907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial.
    Altenberger J; Parissis JT; Costard-Jaeckle A; Winter A; Ebner C; Karavidas A; Sihorsch K; Avgeropoulou E; Weber T; Dimopoulos L; Ulmer H; Poelzl G
    Eur J Heart Fail; 2014 Aug; 16(8):898-906. PubMed ID: 24920349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inodilator levosimendan as a treatment for acute heart failure in various settings.
    Gustafsson F; Guarracino F; Schwinger RHG
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C2-C7. PubMed ID: 29249904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
    Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
    Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG; Nikitin N; McGowan J
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms.
    Fedele F; Bruno N; Brasolin B; Caira C; D'Ambrosi A; Mancone M
    Eur J Heart Fail; 2014 Mar; 16(3):281-8. PubMed ID: 24464960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan meta-analyses: Is there a pattern in the effect on mortality?
    Pollesello P; Parissis J; Kivikko M; Harjola VP
    Int J Cardiol; 2016 Apr; 209():77-83. PubMed ID: 26882190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early experience with Levosimendan in children with ventricular dysfunction.
    Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS
    Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent levosimendan infusions in advanced heart failure: a real world experience.
    Ortis B; Villani A; Oldani M; Giglio A; Ciambellotti F; Facchini M; Parati G; Malfatto G
    J Int Med Res; 2017 Feb; 45(1):361-371. PubMed ID: 28222634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure.
    Bonios MJ; Terrovitis JV; Drakos SG; Katsaros F; Pantsios C; Nanas SN; Kanakakis J; Alexopoulos G; Toumanidis S; Anastasiou-Nana M; Nanas JN
    Int J Cardiol; 2012 Sep; 159(3):225-9. PubMed ID: 21481958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS; Sandell EP
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of levosimendan.
    Antila S; Sundberg S; Lehtonen LA
    Clin Pharmacokinet; 2007; 46(7):535-52. PubMed ID: 17596101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive levosimendan treatment in the management of advanced heart failure.
    Oliva F; Comin-Colet J; Fedele F; Fruhwald F; Gustafsson F; Kivikko M; Borbély A; Pölzl G; Tschöpe C
    Eur Heart J Suppl; 2018 Dec; 20(Suppl I):I11-I20. PubMed ID: 30555280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.